

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.79794625 |
| 2 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.52864656 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.41144399 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 5.41144399 |
| 5 | protein complex biogenesis (GO:0070271) | 5.13980485 |
| 6 | respiratory electron transport chain (GO:0022904) | 5.01762417 |
| 7 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.95695799 |
| 8 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.95695799 |
| 9 | NADH dehydrogenase complex assembly (GO:0010257) | 4.95695799 |
| 10 | polyketide metabolic process (GO:0030638) | 4.95461838 |
| 11 | doxorubicin metabolic process (GO:0044598) | 4.95461838 |
| 12 | daunorubicin metabolic process (GO:0044597) | 4.95461838 |
| 13 | ribosomal small subunit assembly (GO:0000028) | 4.94322001 |
| 14 | electron transport chain (GO:0022900) | 4.85053663 |
| 15 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.78110074 |
| 16 | regulation of mitochondrial translation (GO:0070129) | 4.72948077 |
| 17 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.52597843 |
| 18 | proteasome assembly (GO:0043248) | 4.50068777 |
| 19 | cotranslational protein targeting to membrane (GO:0006613) | 4.49870898 |
| 20 | viral transcription (GO:0019083) | 4.47404870 |
| 21 | protein targeting to ER (GO:0045047) | 4.43525295 |
| 22 | translational termination (GO:0006415) | 4.41497196 |
| 23 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.39944510 |
| 24 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.39944510 |
| 25 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.29094849 |
| 26 | ribosomal large subunit biogenesis (GO:0042273) | 4.27343844 |
| 27 | protein localization to endoplasmic reticulum (GO:0070972) | 4.19446839 |
| 28 | oxidative phosphorylation (GO:0006119) | 4.15955205 |
| 29 | ribosomal small subunit biogenesis (GO:0042274) | 4.05678294 |
| 30 | translation (GO:0006412) | 4.04311315 |
| 31 | cytochrome complex assembly (GO:0017004) | 3.92813227 |
| 32 | cullin deneddylation (GO:0010388) | 3.90021872 |
| 33 | translational elongation (GO:0006414) | 3.87173338 |
| 34 | maturation of SSU-rRNA (GO:0030490) | 3.85835997 |
| 35 | protein deneddylation (GO:0000338) | 3.84566545 |
| 36 | translational initiation (GO:0006413) | 3.72665556 |
| 37 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.63386741 |
| 38 | chromatin remodeling at centromere (GO:0031055) | 3.62817349 |
| 39 | CENP-A containing nucleosome assembly (GO:0034080) | 3.62133694 |
| 40 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.61827063 |
| 41 | DNA deamination (GO:0045006) | 3.61007728 |
| 42 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.58365052 |
| 43 | respiratory chain complex IV assembly (GO:0008535) | 3.57720416 |
| 44 | positive regulation of ligase activity (GO:0051351) | 3.56114544 |
| 45 | protein localization to mitochondrion (GO:0070585) | 3.55936732 |
| 46 | aerobic respiration (GO:0009060) | 3.43244260 |
| 47 | chaperone-mediated protein transport (GO:0072321) | 3.37204093 |
| 48 | viral life cycle (GO:0019058) | 3.37015351 |
| 49 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.35502266 |
| 50 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.35502266 |
| 51 | cellular protein complex disassembly (GO:0043624) | 3.33751841 |
| 52 | rRNA methylation (GO:0031167) | 3.32097096 |
| 53 | heart contraction (GO:0060047) | 3.29440649 |
| 54 | heart process (GO:0003015) | 3.29440649 |
| 55 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.28584341 |
| 56 | intracellular protein transmembrane import (GO:0044743) | 3.26645663 |
| 57 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.22874560 |
| 58 | rRNA processing (GO:0006364) | 3.19498624 |
| 59 | peptidyl-histidine modification (GO:0018202) | 3.18112970 |
| 60 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.17693205 |
| 61 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.17091350 |
| 62 | proton transport (GO:0015992) | 3.15626152 |
| 63 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.15583023 |
| 64 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.15459689 |
| 65 | termination of RNA polymerase III transcription (GO:0006386) | 3.14708229 |
| 66 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.14708229 |
| 67 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.14405267 |
| 68 | mitochondrial transport (GO:0006839) | 3.13532509 |
| 69 | establishment of viral latency (GO:0019043) | 3.13455980 |
| 70 | regulation of ligase activity (GO:0051340) | 3.13069921 |
| 71 | spliceosomal snRNP assembly (GO:0000387) | 3.11012866 |
| 72 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.10380342 |
| 73 | protein-cofactor linkage (GO:0018065) | 3.09889945 |
| 74 | DNA damage response, detection of DNA damage (GO:0042769) | 3.09120428 |
| 75 | quinone biosynthetic process (GO:1901663) | 3.08674552 |
| 76 | ubiquinone biosynthetic process (GO:0006744) | 3.08674552 |
| 77 | hydrogen transport (GO:0006818) | 3.08467094 |
| 78 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.07741951 |
| 79 | rRNA metabolic process (GO:0016072) | 3.07434799 |
| 80 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.06278759 |
| 81 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.04394390 |
| 82 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.03698999 |
| 83 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.03687035 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.02714584 |
| 85 | histone mRNA metabolic process (GO:0008334) | 3.02704469 |
| 86 | ribosome assembly (GO:0042255) | 2.98106729 |
| 87 | cellular response to gamma radiation (GO:0071480) | 2.97269202 |
| 88 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.97119409 |
| 89 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.97119409 |
| 90 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.97119409 |
| 91 | GTP biosynthetic process (GO:0006183) | 2.97062720 |
| 92 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.96151778 |
| 93 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.95686597 |
| 94 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.95686597 |
| 95 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.94325393 |
| 96 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.93708707 |
| 97 | ubiquinone metabolic process (GO:0006743) | 2.93481735 |
| 98 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.92499471 |
| 99 | signal peptide processing (GO:0006465) | 2.92042579 |
| 100 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.91248595 |
| 101 | protein neddylation (GO:0045116) | 2.90224998 |
| 102 | superoxide anion generation (GO:0042554) | 2.88636950 |
| 103 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.88539184 |
| 104 | 7-methylguanosine mRNA capping (GO:0006370) | 2.88521358 |
| 105 | rRNA modification (GO:0000154) | 2.88461236 |
| 106 | aldehyde catabolic process (GO:0046185) | 2.87564987 |
| 107 | 7-methylguanosine RNA capping (GO:0009452) | 2.87048149 |
| 108 | RNA capping (GO:0036260) | 2.87048149 |
| 109 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.85771671 |
| 110 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.84151054 |
| 111 | negative regulation of mast cell activation (GO:0033004) | 2.83201218 |
| 112 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.82953467 |
| 113 | regulation of cellular respiration (GO:0043457) | 2.82427999 |
| 114 | inner mitochondrial membrane organization (GO:0007007) | 2.81280330 |
| 115 | pseudouridine synthesis (GO:0001522) | 2.80665630 |
| 116 | mannosylation (GO:0097502) | 2.80551834 |
| 117 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.79593576 |
| 118 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.77669880 |
| 119 | cellular respiration (GO:0045333) | 2.77655242 |
| 120 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.76973136 |
| 121 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.75486333 |
| 122 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.75486333 |
| 123 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.74646026 |
| 124 | negative regulation of ligase activity (GO:0051352) | 2.69896545 |
| 125 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.69896545 |
| 126 | ATP biosynthetic process (GO:0006754) | 2.68241256 |
| 127 | regulation of oxidative phosphorylation (GO:0002082) | 2.65777850 |
| 128 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.63624167 |
| 129 | tRNA processing (GO:0008033) | 2.63020133 |
| 130 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.61586525 |
| 131 | establishment of protein localization to mitochondrion (GO:0072655) | 2.60222830 |
| 132 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.59860492 |
| 133 | hydrogen ion transmembrane transport (GO:1902600) | 2.59845042 |
| 134 | regulation of hexokinase activity (GO:1903299) | 2.59778660 |
| 135 | regulation of glucokinase activity (GO:0033131) | 2.59778660 |
| 136 | cellular response to oxygen radical (GO:0071450) | 2.57992858 |
| 137 | removal of superoxide radicals (GO:0019430) | 2.57992858 |
| 138 | cellular response to superoxide (GO:0071451) | 2.57992858 |
| 139 | protein targeting to mitochondrion (GO:0006626) | 2.57604418 |
| 140 | establishment of integrated proviral latency (GO:0075713) | 2.55874127 |
| 141 | cellular component biogenesis (GO:0044085) | 2.54669061 |
| 142 | ER overload response (GO:0006983) | 2.53006222 |
| 143 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.52997568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.02389097 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.09671042 |
| 3 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.74374856 |
| 4 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.62263683 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.35538265 |
| 6 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 3.31537097 |
| 7 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.06204012 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.04103566 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.90927542 |
| 10 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.65033773 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.63259371 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.63176584 |
| 13 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.56055004 |
| 14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.48063052 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.48044083 |
| 16 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.41206550 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.36402650 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.22873631 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.21746966 |
| 20 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.18439581 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.15483931 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.13343664 |
| 23 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.06534600 |
| 24 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03828673 |
| 25 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.01843709 |
| 26 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.97115958 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.94196323 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.93130004 |
| 29 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.89411324 |
| 30 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.86784635 |
| 31 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.84899129 |
| 32 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.79397841 |
| 33 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.77093297 |
| 34 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.75629512 |
| 35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.71313439 |
| 36 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.70980237 |
| 37 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.68095445 |
| 38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.67818902 |
| 39 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.66922914 |
| 40 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.62487372 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62087849 |
| 42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.61510241 |
| 43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59261015 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.57076353 |
| 45 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56529266 |
| 46 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.53371972 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.50500537 |
| 48 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.48231168 |
| 49 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.46189220 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.43748175 |
| 51 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.43512689 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.42157325 |
| 53 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.41459618 |
| 54 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.40090169 |
| 55 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.37016156 |
| 56 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.36057478 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.33047448 |
| 58 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.31323027 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31257191 |
| 60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.29979979 |
| 61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29958419 |
| 62 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.29808046 |
| 63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29565097 |
| 64 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.25536317 |
| 65 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.22991885 |
| 66 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.22147036 |
| 67 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.19808192 |
| 68 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.18369342 |
| 69 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.17388230 |
| 70 | FUS_26573619_Chip-Seq_HEK293_Human | 1.13992770 |
| 71 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.13762966 |
| 72 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.12535487 |
| 73 | EWS_26573619_Chip-Seq_HEK293_Human | 1.11766962 |
| 74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10747455 |
| 75 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10497130 |
| 76 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.10081771 |
| 77 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.09741857 |
| 78 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09308533 |
| 79 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08861190 |
| 80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08689776 |
| 81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08250605 |
| 82 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.05684861 |
| 83 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.04774309 |
| 84 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.04601355 |
| 85 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03894007 |
| 86 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.01446716 |
| 87 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.98941070 |
| 88 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.98830681 |
| 89 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.97814578 |
| 90 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97049557 |
| 91 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.94634076 |
| 92 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94563968 |
| 93 | P300_19829295_ChIP-Seq_ESCs_Human | 0.94508081 |
| 94 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.93347860 |
| 95 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.93311825 |
| 96 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.92686098 |
| 97 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91866069 |
| 98 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91828763 |
| 99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91217641 |
| 100 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.91098583 |
| 101 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.90585570 |
| 102 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.90258505 |
| 103 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.89879415 |
| 104 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.89675103 |
| 105 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89611804 |
| 106 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.89381211 |
| 107 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.88820045 |
| 108 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.85031707 |
| 109 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.84704488 |
| 110 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.84412833 |
| 111 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.84264269 |
| 112 | AR_20517297_ChIP-Seq_VCAP_Human | 0.83040143 |
| 113 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.82950740 |
| 114 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.81962676 |
| 115 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81246115 |
| 116 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.80553480 |
| 117 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.80419743 |
| 118 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.78996036 |
| 119 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.78996036 |
| 120 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.77736741 |
| 121 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.77296325 |
| 122 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77278950 |
| 123 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.76482779 |
| 124 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.75738046 |
| 125 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.75499348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009697_abnormal_copulation | 3.61420064 |
| 2 | MP0003186_abnormal_redox_activity | 3.23151613 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 2.90461222 |
| 4 | MP0009379_abnormal_foot_pigmentation | 2.81779266 |
| 5 | MP0006292_abnormal_olfactory_placode | 2.55212073 |
| 6 | MP0002132_abnormal_respiratory_system | 2.50044579 |
| 7 | MP0004147_increased_porphyrin_level | 2.49001938 |
| 8 | MP0006072_abnormal_retinal_apoptosis | 2.43383767 |
| 9 | MP0006036_abnormal_mitochondrial_physio | 2.40881007 |
| 10 | MP0003646_muscle_fatigue | 2.36342560 |
| 11 | MP0005646_abnormal_pituitary_gland | 2.24218676 |
| 12 | MP0008877_abnormal_DNA_methylation | 2.17748217 |
| 13 | MP0010386_abnormal_urinary_bladder | 2.14314796 |
| 14 | MP0000749_muscle_degeneration | 2.12213472 |
| 15 | MP0001986_abnormal_taste_sensitivity | 2.11894241 |
| 16 | MP0002102_abnormal_ear_morphology | 2.05989835 |
| 17 | MP0000372_irregular_coat_pigmentation | 2.00028733 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 1.91386856 |
| 19 | MP0005503_abnormal_tendon_morphology | 1.90568153 |
| 20 | MP0002938_white_spotting | 1.84569982 |
| 21 | MP0002638_abnormal_pupillary_reflex | 1.82843364 |
| 22 | MP0003693_abnormal_embryo_hatching | 1.81306318 |
| 23 | MP0002163_abnormal_gland_morphology | 1.79845309 |
| 24 | MP0006035_abnormal_mitochondrial_morpho | 1.79197318 |
| 25 | MP0003011_delayed_dark_adaptation | 1.78621835 |
| 26 | MP0005084_abnormal_gallbladder_morpholo | 1.78567040 |
| 27 | MP0003941_abnormal_skin_development | 1.77931971 |
| 28 | MP0000015_abnormal_ear_pigmentation | 1.77275534 |
| 29 | MP0003136_yellow_coat_color | 1.74620223 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.73894912 |
| 31 | MP0008058_abnormal_DNA_repair | 1.73762021 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.73333486 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.73040521 |
| 34 | MP0005379_endocrine/exocrine_gland_phen | 1.72877796 |
| 35 | MP0000566_synostosis | 1.69123004 |
| 36 | MP0001188_hyperpigmentation | 1.68839552 |
| 37 | MP0005171_absent_coat_pigmentation | 1.67139182 |
| 38 | MP0008057_abnormal_DNA_replication | 1.64432198 |
| 39 | MP0003111_abnormal_nucleus_morphology | 1.61846772 |
| 40 | MP0008007_abnormal_cellular_replicative | 1.61309741 |
| 41 | MP0009785_altered_susceptibility_to | 1.59067791 |
| 42 | MP0001529_abnormal_vocalization | 1.58143313 |
| 43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.56261830 |
| 44 | MP0001835_abnormal_antigen_presentation | 1.53648420 |
| 45 | MP0003724_increased_susceptibility_to | 1.53067726 |
| 46 | MP0001764_abnormal_homeostasis | 1.52056377 |
| 47 | MP0001853_heart_inflammation | 1.51240796 |
| 48 | MP0008789_abnormal_olfactory_epithelium | 1.46482266 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 1.44481610 |
| 50 | MP0004215_abnormal_myocardial_fiber | 1.44195939 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.43402959 |
| 52 | MP0003786_premature_aging | 1.42607703 |
| 53 | MP0005253_abnormal_eye_physiology | 1.41336334 |
| 54 | MP0010094_abnormal_chromosome_stability | 1.35935593 |
| 55 | MP0008872_abnormal_physiological_respon | 1.33299120 |
| 56 | MP0005408_hypopigmentation | 1.28249574 |
| 57 | MP0005083_abnormal_biliary_tract | 1.24410189 |
| 58 | MP0003195_calcinosis | 1.22163131 |
| 59 | MP0004084_abnormal_cardiac_muscle | 1.21361124 |
| 60 | MP0005085_abnormal_gallbladder_physiolo | 1.21003246 |
| 61 | MP0008995_early_reproductive_senescence | 1.19770572 |
| 62 | MP0002090_abnormal_vision | 1.19288939 |
| 63 | MP0000358_abnormal_cell_content/ | 1.18071916 |
| 64 | MP0003718_maternal_effect | 1.16604740 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 1.15490386 |
| 66 | MP0003436_decreased_susceptibility_to | 1.12835914 |
| 67 | MP0003567_abnormal_fetal_cardiomyocyte | 1.12814644 |
| 68 | MP0000631_abnormal_neuroendocrine_gland | 1.11532053 |
| 69 | MP0003950_abnormal_plasma_membrane | 1.11507457 |
| 70 | MP0001293_anophthalmia | 1.11199058 |
| 71 | MP0005671_abnormal_response_to | 1.10893745 |
| 72 | MP0009764_decreased_sensitivity_to | 1.10234818 |
| 73 | MP0000343_altered_response_to | 1.10213043 |
| 74 | MP0002210_abnormal_sex_determination | 1.09287698 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 1.07666596 |
| 76 | MP0000858_altered_metastatic_potential | 1.07175952 |
| 77 | MP0002972_abnormal_cardiac_muscle | 1.06385154 |
| 78 | MP0004036_abnormal_muscle_relaxation | 1.06267530 |
| 79 | MP0002127_abnormal_cardiovascular_syste | 1.04498649 |
| 80 | MP0003279_aneurysm | 1.04090157 |
| 81 | MP0003880_abnormal_central_pattern | 1.03278823 |
| 82 | MP0005330_cardiomyopathy | 1.02345971 |
| 83 | MP0002160_abnormal_reproductive_system | 1.00807200 |
| 84 | MP0002822_catalepsy | 1.00741033 |
| 85 | MP0003077_abnormal_cell_cycle | 1.00367364 |
| 86 | MP0005389_reproductive_system_phenotype | 0.99366534 |
| 87 | MP0001929_abnormal_gametogenesis | 0.95122806 |
| 88 | MP0005670_abnormal_white_adipose | 0.94866005 |
| 89 | MP0002332_abnormal_exercise_endurance | 0.94743809 |
| 90 | MP0001119_abnormal_female_reproductive | 0.89399928 |
| 91 | MP0008932_abnormal_embryonic_tissue | 0.88596607 |
| 92 | MP0004145_abnormal_muscle_electrophysio | 0.88340426 |
| 93 | MP0001542_abnormal_bone_strength | 0.87971149 |
| 94 | MP0001905_abnormal_dopamine_level | 0.87643591 |
| 95 | MP0003123_paternal_imprinting | 0.87475902 |
| 96 | MP0002419_abnormal_innate_immunity | 0.87071689 |
| 97 | MP0001984_abnormal_olfaction | 0.86327897 |
| 98 | MP0000653_abnormal_sex_gland | 0.85150195 |
| 99 | MP0001485_abnormal_pinna_reflex | 0.85136337 |
| 100 | MP0010030_abnormal_orbit_morphology | 0.84313151 |
| 101 | MP0006054_spinal_hemorrhage | 0.83377196 |
| 102 | MP0002095_abnormal_skin_pigmentation | 0.83312018 |
| 103 | MP0003943_abnormal_hepatobiliary_system | 0.82495472 |
| 104 | MP0001145_abnormal_male_reproductive | 0.81643358 |
| 105 | MP0004133_heterotaxia | 0.81119597 |
| 106 | MP0005266_abnormal_metabolism | 0.80528187 |
| 107 | MP0005645_abnormal_hypothalamus_physiol | 0.80307905 |
| 108 | MP0005025_abnormal_response_to | 0.79607359 |
| 109 | MP0004957_abnormal_blastocyst_morpholog | 0.79120650 |
| 110 | MP0002138_abnormal_hepatobiliary_system | 0.78593208 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.78431602 |
| 112 | MP0005000_abnormal_immune_tolerance | 0.78310056 |
| 113 | MP0005636_abnormal_mineral_homeostasis | 0.78097846 |
| 114 | MP0002736_abnormal_nociception_after | 0.77896662 |
| 115 | MP0000538_abnormal_urinary_bladder | 0.77179157 |
| 116 | MP0005248_abnormal_Harderian_gland | 0.77008589 |
| 117 | MP0005332_abnormal_amino_acid | 0.76848127 |
| 118 | MP0002234_abnormal_pharynx_morphology | 0.76249806 |
| 119 | MP0003121_genomic_imprinting | 0.76177984 |
| 120 | MP0008469_abnormal_protein_level | 0.75727812 |
| 121 | MP0005620_abnormal_muscle_contractility | 0.74034359 |
| 122 | MP0001186_pigmentation_phenotype | 0.73924735 |
| 123 | MP0004142_abnormal_muscle_tone | 0.73047144 |
| 124 | MP0008775_abnormal_heart_ventricle | 0.72555776 |
| 125 | MP0003122_maternal_imprinting | 0.72429879 |
| 126 | MP0001881_abnormal_mammary_gland | 0.71661615 |
| 127 | MP0000681_abnormal_thyroid_gland | 0.71348271 |
| 128 | MP0003137_abnormal_impulse_conducting | 0.68589057 |
| 129 | MP0005365_abnormal_bile_salt | 0.68231796 |
| 130 | MP0001919_abnormal_reproductive_system | 0.67747318 |
| 131 | MP0002106_abnormal_muscle_physiology | 0.67539726 |
| 132 | MP0005376_homeostasis/metabolism_phenot | 0.67410372 |
| 133 | MP0005410_abnormal_fertilization | 0.67356566 |
| 134 | MP0001544_abnormal_cardiovascular_syste | 0.66823025 |
| 135 | MP0005385_cardiovascular_system_phenoty | 0.66823025 |
| 136 | MP0008873_increased_physiological_sensi | 0.63839579 |
| 137 | MP0004019_abnormal_vitamin_homeostasis | 0.63333719 |
| 138 | MP0000647_abnormal_sebaceous_gland | 0.62687911 |
| 139 | MP0002233_abnormal_nose_morphology | 0.62520206 |
| 140 | MP0000313_abnormal_cell_death | 0.61875250 |
| 141 | MP0001697_abnormal_embryo_size | 0.59485082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.54700305 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.23853490 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.92430471 |
| 4 | Progressive macrocephaly (HP:0004481) | 4.63041310 |
| 5 | Acute encephalopathy (HP:0006846) | 4.62775409 |
| 6 | Increased CSF lactate (HP:0002490) | 4.47034313 |
| 7 | Hepatic necrosis (HP:0002605) | 4.28779654 |
| 8 | Hepatocellular necrosis (HP:0001404) | 4.23504411 |
| 9 | 3-Methylglutaconic aciduria (HP:0003535) | 3.94455043 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.89928570 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.89928570 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 3.64728922 |
| 13 | Exercise intolerance (HP:0003546) | 3.59337266 |
| 14 | Cerebral edema (HP:0002181) | 3.39827820 |
| 15 | Lipid accumulation in hepatocytes (HP:0006561) | 3.39078028 |
| 16 | Increased serum lactate (HP:0002151) | 3.33690860 |
| 17 | Type I transferrin isoform profile (HP:0003642) | 3.26128520 |
| 18 | Lactic acidosis (HP:0003128) | 3.25439604 |
| 19 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.19063032 |
| 20 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.15554252 |
| 21 | Renal Fanconi syndrome (HP:0001994) | 3.10947993 |
| 22 | Macrocytic anemia (HP:0001972) | 3.06741141 |
| 23 | Microvesicular hepatic steatosis (HP:0001414) | 2.93350038 |
| 24 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.93195348 |
| 25 | Respiratory failure (HP:0002878) | 2.87833241 |
| 26 | Chromsome breakage (HP:0040012) | 2.83712513 |
| 27 | Increased intramyocellular lipid droplets (HP:0012240) | 2.80753326 |
| 28 | * Optic disc pallor (HP:0000543) | 2.79760992 |
| 29 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.72559005 |
| 30 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.72559005 |
| 31 | Abnormal protein glycosylation (HP:0012346) | 2.72559005 |
| 32 | Abnormal glycosylation (HP:0012345) | 2.72559005 |
| 33 | Reduced antithrombin III activity (HP:0001976) | 2.67403034 |
| 34 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.66592357 |
| 35 | Renal cortical cysts (HP:0000803) | 2.65983365 |
| 36 | Abnormal hair whorl (HP:0010721) | 2.62888943 |
| 37 | Abnormal number of erythroid precursors (HP:0012131) | 2.60840143 |
| 38 | Abnormality of methionine metabolism (HP:0010901) | 2.54062130 |
| 39 | Congenital, generalized hypertrichosis (HP:0004540) | 2.50054094 |
| 40 | Generalized aminoaciduria (HP:0002909) | 2.49151794 |
| 41 | Exertional dyspnea (HP:0002875) | 2.47794912 |
| 42 | Supernumerary spleens (HP:0009799) | 2.44646929 |
| 43 | Increased muscle lipid content (HP:0009058) | 2.39810053 |
| 44 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.35580839 |
| 45 | Abnormality of renal resorption (HP:0011038) | 2.26119462 |
| 46 | Increased IgM level (HP:0003496) | 2.24344003 |
| 47 | Abnormality of urine glucose concentration (HP:0011016) | 2.22503629 |
| 48 | Glycosuria (HP:0003076) | 2.22503629 |
| 49 | Abnormality of serum amino acid levels (HP:0003112) | 2.21541770 |
| 50 | Colon cancer (HP:0003003) | 2.21063542 |
| 51 | Proximal tubulopathy (HP:0000114) | 2.18014861 |
| 52 | Hypothermia (HP:0002045) | 2.17158497 |
| 53 | Septo-optic dysplasia (HP:0100842) | 2.17091665 |
| 54 | Patchy hypopigmentation of hair (HP:0011365) | 2.15262225 |
| 55 | Leukodystrophy (HP:0002415) | 2.14578997 |
| 56 | True hermaphroditism (HP:0010459) | 2.12394236 |
| 57 | Pancreatic fibrosis (HP:0100732) | 2.12037980 |
| 58 | Nausea (HP:0002018) | 2.11546616 |
| 59 | Type 2 muscle fiber atrophy (HP:0003554) | 2.11024084 |
| 60 | Pancytopenia (HP:0001876) | 2.11003740 |
| 61 | Facial cleft (HP:0002006) | 2.08186927 |
| 62 | Abnormality of glycolysis (HP:0004366) | 2.06266232 |
| 63 | Increased serum pyruvate (HP:0003542) | 2.06266232 |
| 64 | Birth length less than 3rd percentile (HP:0003561) | 2.05050937 |
| 65 | Fair hair (HP:0002286) | 2.04253202 |
| 66 | Molar tooth sign on MRI (HP:0002419) | 2.04135134 |
| 67 | Abnormality of midbrain morphology (HP:0002418) | 2.04135134 |
| 68 | Oral leukoplakia (HP:0002745) | 2.00170696 |
| 69 | Lethargy (HP:0001254) | 1.99374185 |
| 70 | Respiratory difficulties (HP:0002880) | 1.99125086 |
| 71 | X-linked dominant inheritance (HP:0001423) | 1.96153224 |
| 72 | Hyperphosphaturia (HP:0003109) | 1.95784626 |
| 73 | Hyperglycinemia (HP:0002154) | 1.91600777 |
| 74 | Pallor (HP:0000980) | 1.87647486 |
| 75 | Abnormality of the labia minora (HP:0012880) | 1.87379344 |
| 76 | Median cleft lip (HP:0000161) | 1.87274692 |
| 77 | Palpitations (HP:0001962) | 1.86445483 |
| 78 | Absent septum pellucidum (HP:0001331) | 1.85033085 |
| 79 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.83765363 |
| 80 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.83763040 |
| 81 | Opisthotonus (HP:0002179) | 1.83722983 |
| 82 | Hypoglycemic coma (HP:0001325) | 1.81922634 |
| 83 | Hypokinesia (HP:0002375) | 1.81727985 |
| 84 | Poor head control (HP:0002421) | 1.81622001 |
| 85 | Aplastic anemia (HP:0001915) | 1.81414847 |
| 86 | Esophageal neoplasm (HP:0100751) | 1.81107188 |
| 87 | Neoplasm of head and neck (HP:0012288) | 1.81107188 |
| 88 | Megaloblastic anemia (HP:0001889) | 1.80720966 |
| 89 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.80674758 |
| 90 | Abnormality of alanine metabolism (HP:0010916) | 1.80674758 |
| 91 | Hyperalaninemia (HP:0003348) | 1.80674758 |
| 92 | Stenosis of the external auditory canal (HP:0000402) | 1.80199435 |
| 93 | Abnormality of the anterior horn cell (HP:0006802) | 1.79377000 |
| 94 | Degeneration of anterior horn cells (HP:0002398) | 1.79377000 |
| 95 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.77147972 |
| 96 | Abnormality of vitamin B metabolism (HP:0004340) | 1.76331268 |
| 97 | Methylmalonic acidemia (HP:0002912) | 1.75788446 |
| 98 | Dicarboxylic aciduria (HP:0003215) | 1.74787814 |
| 99 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.74787814 |
| 100 | Duplicated collecting system (HP:0000081) | 1.73543274 |
| 101 | Abnormality of the renal collecting system (HP:0004742) | 1.73285984 |
| 102 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.72953217 |
| 103 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.71524364 |
| 104 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.71318431 |
| 105 | Nephrogenic diabetes insipidus (HP:0009806) | 1.70600393 |
| 106 | White forelock (HP:0002211) | 1.69728986 |
| 107 | Amniotic constriction ring (HP:0009775) | 1.68341251 |
| 108 | Abnormality of placental membranes (HP:0011409) | 1.68341251 |
| 109 | Muscle fiber atrophy (HP:0100295) | 1.68005175 |
| 110 | Emotional lability (HP:0000712) | 1.67989105 |
| 111 | Hypoplasia of the fovea (HP:0007750) | 1.67073767 |
| 112 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.67073767 |
| 113 | Meckel diverticulum (HP:0002245) | 1.66154333 |
| 114 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.65110114 |
| 115 | Medial flaring of the eyebrow (HP:0010747) | 1.64765995 |
| 116 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.64580983 |
| 117 | Blindness (HP:0000618) | 1.63921980 |
| 118 | Congenital primary aphakia (HP:0007707) | 1.62274919 |
| 119 | Adrenal hypoplasia (HP:0000835) | 1.62272825 |
| 120 | Dilated cardiomyopathy (HP:0001644) | 1.61117419 |
| 121 | Neoplasm of the adrenal gland (HP:0100631) | 1.60863149 |
| 122 | Renal tubular dysfunction (HP:0000124) | 1.59463917 |
| 123 | Pancreatic cysts (HP:0001737) | 1.59140820 |
| 124 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.59023827 |
| 125 | Retrobulbar optic neuritis (HP:0100654) | 1.58878449 |
| 126 | Optic neuritis (HP:0100653) | 1.58878449 |
| 127 | Lipoatrophy (HP:0100578) | 1.58797077 |
| 128 | CNS demyelination (HP:0007305) | 1.58560396 |
| 129 | Abnormality of the ileum (HP:0001549) | 1.58165716 |
| 130 | Rhabdomyolysis (HP:0003201) | 1.57413423 |
| 131 | Methylmalonic aciduria (HP:0012120) | 1.57405625 |
| 132 | Alveolar cell carcinoma (HP:0006519) | 1.57196256 |
| 133 | Bone marrow hypocellularity (HP:0005528) | 1.56848187 |
| 134 | Reticulocytopenia (HP:0001896) | 1.56761580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.05838749 |
| 2 | ZAK | 2.91833804 |
| 3 | PRPF4B | 2.52897472 |
| 4 | CASK | 2.49183628 |
| 5 | STK16 | 2.43974899 |
| 6 | VRK1 | 2.39959780 |
| 7 | NEK1 | 2.33709091 |
| 8 | TRIM28 | 2.21990170 |
| 9 | NME1 | 2.15117332 |
| 10 | MAP2K7 | 2.07913382 |
| 11 | EIF2AK3 | 2.01483462 |
| 12 | EIF2AK1 | 2.00415342 |
| 13 | TXK | 1.99973444 |
| 14 | MUSK | 1.98215431 |
| 15 | MAP3K14 | 1.97486272 |
| 16 | OBSCN | 1.95177774 |
| 17 | CDC7 | 1.92109123 |
| 18 | STK38L | 1.91935210 |
| 19 | BMPR2 | 1.87464000 |
| 20 | MAP4K2 | 1.87388860 |
| 21 | SRPK1 | 1.85681321 |
| 22 | YES1 | 1.81401978 |
| 23 | MYLK | 1.80277653 |
| 24 | NME2 | 1.77409473 |
| 25 | ERBB3 | 1.77143567 |
| 26 | TAF1 | 1.76520126 |
| 27 | STK24 | 1.72379458 |
| 28 | PIM2 | 1.67386649 |
| 29 | BCKDK | 1.62074079 |
| 30 | PIK3CG | 1.61814933 |
| 31 | IRAK3 | 1.61225660 |
| 32 | EPHA3 | 1.59146964 |
| 33 | INSRR | 1.55536809 |
| 34 | ADRBK2 | 1.55448776 |
| 35 | TLK1 | 1.55023871 |
| 36 | EIF2AK2 | 1.50738919 |
| 37 | MKNK1 | 1.43649862 |
| 38 | PLK4 | 1.42448115 |
| 39 | MKNK2 | 1.41996605 |
| 40 | CDK8 | 1.41743164 |
| 41 | PBK | 1.41389645 |
| 42 | BUB1 | 1.40034477 |
| 43 | GRK7 | 1.39335893 |
| 44 | IRAK4 | 1.28504621 |
| 45 | TNIK | 1.27759307 |
| 46 | AKT3 | 1.26404012 |
| 47 | BMPR1B | 1.23494771 |
| 48 | CDK19 | 1.22345643 |
| 49 | MAP3K12 | 1.16874572 |
| 50 | PIK3CA | 1.14159141 |
| 51 | TTK | 1.10681428 |
| 52 | WEE1 | 1.10598460 |
| 53 | DYRK2 | 1.08805256 |
| 54 | SIK3 | 1.05292614 |
| 55 | PINK1 | 1.02286248 |
| 56 | MAPK15 | 0.99446586 |
| 57 | GRK1 | 0.98720669 |
| 58 | PLK3 | 0.98129117 |
| 59 | IKBKB | 0.95715285 |
| 60 | TEC | 0.92997122 |
| 61 | CCNB1 | 0.91742888 |
| 62 | NUAK1 | 0.88324074 |
| 63 | NEK6 | 0.87306015 |
| 64 | MST4 | 0.87001988 |
| 65 | TAOK2 | 0.86313936 |
| 66 | BRAF | 0.84777488 |
| 67 | CSNK1G1 | 0.83289883 |
| 68 | BCR | 0.83269941 |
| 69 | EPHA2 | 0.80611650 |
| 70 | TSSK6 | 0.78838943 |
| 71 | OXSR1 | 0.78542618 |
| 72 | NEK9 | 0.77699956 |
| 73 | IRAK1 | 0.77119143 |
| 74 | CSNK1G3 | 0.77046194 |
| 75 | ILK | 0.73091811 |
| 76 | DAPK3 | 0.71758777 |
| 77 | WNK4 | 0.67821887 |
| 78 | FRK | 0.63990423 |
| 79 | DAPK1 | 0.63762467 |
| 80 | NLK | 0.63099297 |
| 81 | STK39 | 0.62599570 |
| 82 | ACVR1B | 0.61749622 |
| 83 | SGK2 | 0.61748242 |
| 84 | PLK2 | 0.60695360 |
| 85 | TRPM7 | 0.60564929 |
| 86 | CSNK1G2 | 0.59620757 |
| 87 | CSNK2A1 | 0.59574098 |
| 88 | RPS6KA5 | 0.58993837 |
| 89 | CHEK2 | 0.55891462 |
| 90 | CHUK | 0.54988355 |
| 91 | CDK3 | 0.53357229 |
| 92 | LIMK1 | 0.52204899 |
| 93 | PLK1 | 0.52115441 |
| 94 | ABL2 | 0.51166957 |
| 95 | RPS6KB1 | 0.49598614 |
| 96 | TESK1 | 0.49412976 |
| 97 | DYRK3 | 0.49350333 |
| 98 | SCYL2 | 0.48972930 |
| 99 | TIE1 | 0.48755827 |
| 100 | PRKG2 | 0.48518839 |
| 101 | PIM1 | 0.47573773 |
| 102 | ATR | 0.46259769 |
| 103 | CSNK1A1L | 0.45511723 |
| 104 | PAK4 | 0.45351190 |
| 105 | PASK | 0.45071834 |
| 106 | AURKB | 0.44014300 |
| 107 | MAPKAPK3 | 0.43974439 |
| 108 | MAP2K6 | 0.43439706 |
| 109 | PRKCG | 0.43129674 |
| 110 | PDK2 | 0.43116585 |
| 111 | TGFBR1 | 0.42932426 |
| 112 | MAPK13 | 0.42892401 |
| 113 | IKBKE | 0.41767292 |
| 114 | WNK3 | 0.41091017 |
| 115 | STK4 | 0.40967821 |
| 116 | PRKCI | 0.40965938 |
| 117 | PRKCE | 0.40598582 |
| 118 | BRSK2 | 0.39772225 |
| 119 | CDK7 | 0.39670079 |
| 120 | ERN1 | 0.39637544 |
| 121 | MAP3K5 | 0.38269468 |
| 122 | AURKA | 0.37766042 |
| 123 | STK3 | 0.37452602 |
| 124 | MAP3K4 | 0.37039688 |
| 125 | TYK2 | 0.36916394 |
| 126 | KDR | 0.36667950 |
| 127 | KIT | 0.36029927 |
| 128 | ERBB4 | 0.35803008 |
| 129 | PHKG2 | 0.35613293 |
| 130 | PHKG1 | 0.35613293 |
| 131 | CSNK1A1 | 0.35439483 |
| 132 | PRKCD | 0.35397313 |
| 133 | PAK1 | 0.35191854 |
| 134 | CSNK2A2 | 0.34626076 |
| 135 | LYN | 0.34439804 |
| 136 | BTK | 0.33872579 |
| 137 | CHEK1 | 0.32801100 |
| 138 | MAPKAPK5 | 0.32791427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.36755409 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.80365995 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.62773343 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.95254717 |
| 5 | Huntingtons disease_Homo sapiens_hsa05016 | 2.81592531 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.72050763 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.62689113 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.62037008 |
| 9 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.57516718 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 2.05945057 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.03605966 |
| 12 | Mismatch repair_Homo sapiens_hsa03430 | 2.00717767 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.98967033 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 1.96272657 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.95710457 |
| 16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.93262150 |
| 17 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.81137569 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.44846432 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.44447870 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.44074325 |
| 21 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.32563197 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.32107022 |
| 23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.30865139 |
| 24 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.30855127 |
| 25 | Spliceosome_Homo sapiens_hsa03040 | 1.28998021 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.27272813 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.27237027 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.24957778 |
| 29 | Purine metabolism_Homo sapiens_hsa00230 | 1.23050828 |
| 30 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.22077102 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.21011671 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.20431176 |
| 33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.19357209 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.17147997 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16273356 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.15550332 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.14927369 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.13364127 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.09029067 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08086971 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06910454 |
| 42 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.00006970 |
| 43 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.98164052 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.90546148 |
| 45 | Metabolic pathways_Homo sapiens_hsa01100 | 0.87642415 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.86960539 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.86385850 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85305661 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.84589004 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84222855 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.83803131 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83412543 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.83082549 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80312008 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80299101 |
| 56 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80093440 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79439206 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 0.78677585 |
| 59 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78404515 |
| 60 | RNA transport_Homo sapiens_hsa03013 | 0.76404350 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75070966 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74765195 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74740403 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72908856 |
| 65 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.72016798 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71784107 |
| 67 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71759643 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71588737 |
| 69 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.69866141 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69405139 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69149002 |
| 72 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.68630859 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65836525 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.63299167 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62620963 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.62427388 |
| 77 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.62407638 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60701690 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60255286 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58431590 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58050900 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57826418 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55767717 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.54728141 |
| 85 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54186589 |
| 86 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53474763 |
| 87 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52369656 |
| 88 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.52260091 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52208910 |
| 90 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51307477 |
| 91 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50642593 |
| 92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.48801366 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47135462 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46044466 |
| 95 | Cell cycle_Homo sapiens_hsa04110 | 0.44150430 |
| 96 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.43968921 |
| 97 | Measles_Homo sapiens_hsa05162 | 0.43523397 |
| 98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.43077376 |
| 99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.42887197 |
| 100 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42319686 |
| 101 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42081789 |
| 102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39100647 |
| 103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38702039 |
| 104 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.36989123 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36869816 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.36704506 |
| 107 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.36660222 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.35861336 |
| 109 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.34989590 |
| 110 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34713551 |
| 111 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33285352 |
| 112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32954756 |
| 113 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.31263507 |
| 114 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.31207381 |
| 115 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.30578941 |
| 116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30342572 |
| 117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28858075 |
| 118 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.27113927 |
| 119 | Mineral absorption_Homo sapiens_hsa04978 | 0.21766167 |
| 120 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.21735406 |
| 121 | Alcoholism_Homo sapiens_hsa05034 | 0.15859398 |

